WHG
VRTX icon

Westwood Holdings Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Westwood Holdings Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
+626
New +$277K ﹤0.01% 562
2025
Q3 		– Sell
-154,217
Closed -$68.7M – 515
2025
Q2 		$68.7M Buy
154,217
+80,249
+108% +$37M 0.49% 85
2025
Q1 		$35.9M Buy
73,968
+70,803
+2,237% +$33M 0.27% 127
2024
Q4 		$1.27M Buy
+3,165
New +$1.47M 0.01% 354

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Westwood Holdings Group's VRTX Position: Q2 2026 in Review

Westwood Holdings Group opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 626 shares worth $311K. The stake represents ﹤0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Westwood Holdings Group previously reported a position in VRTX as recently as Q2 2025.

Westwood Holdings Group first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $68.7M in Q2 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Westwood Holdings Group held 626 shares of Vertex Pharmaceuticals worth $311K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Westwood Holdings Group position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Westwood Holdings Group's portfolio in Q2 2026, its #562 holding.
  • Westwood Holdings Group first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Westwood Holdings Group's Vertex Pharmaceuticals position peaked at $68.7M in Q2 2025.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.